BACKGROUND: CD154 blockade-based immunosuppression successfully prevents both humoral and cellular adaptive immune responses in baboons receiving α1,3-galactosyltransferase gene-knockout (GTKO) pig organs. Using a GTKO pig artery transplantation model in baboons, we evaluated the efficacy of CD28/B7 costimulatory pathway blockade in comparison with CD154 blockade. METHODS: Baboons received artery patch grafts from GTKO pigs, with no (Group1), anti-CD154mAb-based (Group2), or CTLA4-Ig-based (Group3) immunosuppressive therapy. Anti-pig IgM and IgG antibody and cellular responses were monitored. Xenografts were immunohistologically evaluated for antibody and complement deposition, and cellular infiltration. RESULTS: Group1 baboons developed increased IgM and IgG antibody and cellular responses against GTKO antigens. In Group2, anti-CD154mAb alone prevented the development of both IgM and IgG antibody and cellular responses,but not cellular infiltration of the graft. In the single baboon that received anti-thymocyte globulin (ATG) + mycophenolate mofetil (MMF) + anti-CD154mAb, cellular infiltration of the graft was not seen. In Group3, CTLA4-Ig with ATG + MMF inhibited the cellular proliferative response to pig antigens but did not prevent the IgG response or cellular infiltration. CONCLUSIONS: (i) Artery patch transplantation is a simple model to monitor the adaptive immune response to xenografts; (ii) anti-CD154mAb prevents sensitization but not cellular infiltration (but, without anticoagulation, may result in early thrombosis of a pig xenograft); (iii) although in only one baboon, the addition of ATG and MMF prevents cellular infiltration and (iv) replacement of anti-CD154mAb by CTLA4-Ig (at the doses used), even in combination with ATG and MMF, prevents the cellular proliferative response to GTKO pig antigens but is insufficient to prevent the development of anti-pig antibodies.
BACKGROUND: CD154 blockade-based immunosuppression successfully prevents both humoral and cellular adaptive immune responses in baboons receiving α1,3-galactosyltransferase gene-knockout (GTKO) pig organs. Using a GTKO pig artery transplantation model in baboons, we evaluated the efficacy of CD28/B7 costimulatory pathway blockade in comparison with CD154 blockade. METHODS:Baboons received artery patch grafts from GTKO pigs, with no (Group1), anti-CD154mAb-based (Group2), or CTLA4-Ig-based (Group3) immunosuppressive therapy. Anti-pig IgM and IgG antibody and cellular responses were monitored. Xenografts were immunohistologically evaluated for antibody and complement deposition, and cellular infiltration. RESULTS: Group1 baboons developed increased IgM and IgG antibody and cellular responses against GTKO antigens. In Group2, anti-CD154mAb alone prevented the development of both IgM and IgG antibody and cellular responses,but not cellular infiltration of the graft. In the single baboon that received anti-thymocyte globulin (ATG) + mycophenolate mofetil (MMF) + anti-CD154mAb, cellular infiltration of the graft was not seen. In Group3, CTLA4-Ig with ATG + MMF inhibited the cellular proliferative response to pig antigens but did not prevent the IgG response or cellular infiltration. CONCLUSIONS: (i) Artery patch transplantation is a simple model to monitor the adaptive immune response to xenografts; (ii) anti-CD154mAb prevents sensitization but not cellular infiltration (but, without anticoagulation, may result in early thrombosis of a pig xenograft); (iii) although in only one baboon, the addition of ATG and MMF prevents cellular infiltration and (iv) replacement of anti-CD154mAb by CTLA4-Ig (at the doses used), even in combination with ATG and MMF, prevents the cellular proliferative response to GTKO pig antigens but is insufficient to prevent the development of anti-pig antibodies.
Authors: L Bühler; K Yamada; H Kitamura; I P Alwayn; M Basker; J Z Appel; R B Colvin; M E White-Scharf; D H Sachs; S C Robson; M Awwad; D K Cooper Journal: Transplantation Date: 2001-12-15 Impact factor: 4.939
Authors: L Bühler; M Basker; I P Alwayn; C Goepfert; H Kitamura; T Kawai; S Gojo; T Kozlowski; F L Ierino; M Awwad; D H Sachs; R Sackstein; S C Robson; D K Cooper Journal: Transplantation Date: 2000-11-15 Impact factor: 4.939
Authors: Yifan Dai; Todd D Vaught; Jeremy Boone; Shu-Hung Chen; Carol J Phelps; Suyapa Ball; Jeff A Monahan; Peter M Jobst; Kenneth J McCreath; Ashley E Lamborn; Jamie L Cowell-Lucero; Kevin D Wells; Alan Colman; Irina A Polejaeva; David L Ayares Journal: Nat Biotechnol Date: 2002-03 Impact factor: 54.908
Authors: L Bühler; M Awwad; M Basker; S Gojo; A Watts; S Treter; K Nash; G Oravec; Q Chang; A Thall; J D Down; M Sykes; D Andrews; R Sackstein; M E White-Scharf; D H Sachs; D K Cooper Journal: Transplantation Date: 2000-06-15 Impact factor: 4.939
Authors: P Thompson; K Cardona; M Russell; I R Badell; V Shaffer; G Korbutt; G R Rayat; J Cano; M Song; W Jiang; E Strobert; R Rajotte; T Pearson; A D Kirk; C P Larsen Journal: Am J Transplant Date: 2011-05 Impact factor: 8.086
Authors: Carol J Phelps; Chihiro Koike; Todd D Vaught; Jeremy Boone; Kevin D Wells; Shu-Hung Chen; Suyapa Ball; Susan M Specht; Irina A Polejaeva; Jeff A Monahan; Pete M Jobst; Sugandha B Sharma; Ashley E Lamborn; Amy S Garst; Marilyn Moore; Anthony J Demetris; William A Rudert; Rita Bottino; Suzanne Bertera; Massimo Trucco; Thomas E Starzl; Yifan Dai; David L Ayares Journal: Science Date: 2002-12-19 Impact factor: 47.728
Authors: Christoph Knosalla; Bernd Gollackner; Leo Bühler; Nicolas J Mueller; Stuart Houser; Shamila Mauiyyedi; David H Sachs; Simon C Robson; Jay Fishman; Henk-Jan Schuurman; Michel Awwad; David K C Cooper Journal: Am J Transplant Date: 2003-12 Impact factor: 8.086
Authors: Tao Li; Whayoung Lee; Hidetaka Hara; Cassandra Long; Mohamed Ezzelarab; David Ayares; Hai Huang; Yi Wang; Charles T Esmon; David K C Cooper; Hayato Iwase Journal: Transplantation Date: 2017-10 Impact factor: 4.939
Authors: Hayato Iwase; Burcin Ekser; Vikas Satyananda; Jay Bhama; Hidetaka Hara; Mohamed Ezzelarab; Edwin Klein; Robert Wagner; Cassandra Long; Jnanesh Thacker; Jiang Li; Hao Zhou; Maolin Jiang; Santosh Nagaraju; Huidong Zhou; Massimiliano Veroux; Pietro Bajona; Martin Wijkstrom; Yi Wang; Carol Phelps; Nikolai Klymiuk; Eckhard Wolf; David Ayares; David K C Cooper Journal: Xenotransplantation Date: 2015-04-03 Impact factor: 3.907
Authors: Hayato Iwase; Burcin Ekser; Huidong Zhou; Hong Liu; Vikas Satyananda; Rishab Humar; Pooja Humar; Hidetaka Hara; Cassandra Long; Jay K Bhama; Pietro Bajona; Yi Wang; Martin Wijkstrom; David Ayares; Mohamed B Ezzelarab; David K C Cooper Journal: Xenotransplantation Date: 2015-08-21 Impact factor: 3.907
Authors: Takayuki Yamamoto; Qi Li; Hidetaka Hara; Liaoran Wang; Hongmin Zhou; Juan Li; Devin E Eckhoff; A Joseph Tector; Edwin C Klein; Ray Lovingood; Mohamed Ezzelarab; David Ayares; Yi Wang; David K C Cooper; Hayato Iwase Journal: Transpl Immunol Date: 2018-08-06 Impact factor: 1.708
Authors: H Iwase; B Ekser; V Satyananda; H Zhou; H Hara; P Bajona; M Wijkstrom; J K Bhama; C Long; M Veroux; Y Wang; Y Dai; C Phelps; D Ayares; M B Ezzelarab; D K C Cooper Journal: Transpl Immunol Date: 2015-02-14 Impact factor: 1.708
Authors: David K C Cooper; Vikas Satyananda; Burcin Ekser; Dirk J van der Windt; Hidetaka Hara; Mohamed B Ezzelarab; Henk-Jan Schuurman Journal: Xenotransplantation Date: 2014-09-01 Impact factor: 3.907
Authors: Agnes M Azimzadeh; Guerard W Byrne; Mohamed Ezzelarab; Emily Welty; Gheorghe Braileanu; Xiangfei Cheng; Simon C Robson; Christopher G A McGregor; David K C Cooper; Richard N Pierson Journal: Xenotransplantation Date: 2014-09-01 Impact factor: 3.907